✦ LIBER ✦

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature

✍ Scribed by Claudia Tellez; Al B. Benson III; Michael T. Lyster; Mark Talamonti; John Shaw; Michael A. Braun; Albert A. Nemcek Jr.; Robert L. Vogelzang

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 130 KB
Volume: 82
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19980401)82:7<1250::aid-cncr7>3.0.co;2-j

No coin nor oath required. For personal study only.

✦ Synopsis

an injection of a bovine collagen material with cisplatin (10 mg/mL), doxorubicin (3 mg/mL), and mitomycin C (3 mg/mL). Repeat treatments were performed at

📜 SIMILAR VOLUMES

A phase I-II trial of mitoxantrone by he

A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver

✍ Dennie V. Jones Jr.; Yehuda Z. Patt; Jaffer A. Ajani; James Abbruzzese; Bernard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

A Phase II trial of methotrexate, vinbla

A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix

✍ Christos A. Papadimitriou; Meletios A. Dimopoulos; Nikolaos Giannakoulis; Kyrill 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## Background: Patients with metastatic carcinoma of the uterine cervix have limited survival. thus, new chemotherapeutic agents and combinations are needed to improve patient outcome. ## Methods: Twenty-seven patients with stage iv primary or recurrent carcinoma of the uterine cervix were assign

Iodine-125 brachytherapy in the treatmen

Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver

✍ Rafael Martinez-Monge; Subir Nag; Carol A. Nieroda; Edward W. Martin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

## BACKGROUND. The liver is the site of distant failure in Ͼ 33% of patients with colorectal adenocarcinoma. Liver resection is the only potentially curative option in these patients. Patients with incompletely resected liver lesions (due to the proximity to critical vascular structures) are at hi

Metastatic carcinoma to the tongue. A re

Metastatic carcinoma to the tongue. A report of two cases and a review of the literature

✍ Robert Y. Kim; Stephen R. Perry; David S. Levy 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

A phase II study of constant-infusion fl

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma

✍ Mary J. Wilkinson; John W. Frye; Eric J. Small; Alan P. Venook; Peter R. Carroll 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Background. Twenty-nine patients with metastatic renal cell carcinoma (RCC) were treated with constantinfusion floxuridine (FUdR, Roche Laboratories, Nut-Methods. The initial dosage was 0.075 mg/kg/day for 14 days every 28 days and was increased or decreased by 0.025-mg/kg/day increments at each sub

A phase II trial of methotrexate, cispla

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

✍ William K. Oh; Judith Manola; Jerome P. Richie; Kevin R. Loughlin; Philip W. Kan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

The current treatment of advanced urothelial carcinoma generates high response rates but is associated with poor overall survival. The current study evaluated the efficacy and toxicity of a new combination of active drugs in the treatment of urothelial carcinoma. ## METHODS. Twenty-four patients